| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 27.78B | 8.14B | 11.97B | -27.59B | 26.50B |
| Gross Profit | 27.78B | 8.14B | 11.97B | -27.59B | 26.50B |
| EBITDA | 5.13B | 2.93B | 3.06B | -233.86M | 3.00B |
| Net Income | 3.98B | 2.29B | 1.70B | -1.01B | -2.04B |
Balance Sheet | |||||
| Total Assets | 211.90B | 181.88B | 174.07B | 160.25B | 188.23B |
| Cash, Cash Equivalents and Short-Term Investments | 7.70B | 2.44B | 1.59B | 1.81B | 7.17B |
| Total Debt | 6.03B | 4.72B | 4.87B | 5.08B | 8.24B |
| Total Liabilities | 190.57B | 163.20B | 156.08B | 143.35B | 169.12B |
| Stockholders Equity | 20.09B | 17.49B | 17.82B | 16.73B | 18.94B |
Cash Flow | |||||
| Free Cash Flow | 2.17B | 3.51B | 788.00M | 839.48M | 242.00M |
| Operating Cash Flow | 2.28B | 3.61B | 832.00M | 873.46M | 278.00M |
| Investing Cash Flow | 1.09B | -832.00M | -360.00M | -39.00M | -726.00M |
| Financing Cash Flow | -1.57B | -1.70B | -1.21B | -2.52B | 1.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $12.13B | 10.08 | 20.32% | 0.74% | 3.96% | 18.81% | |
76 Outperform | $13.50B | 12.91 | 7.07% | 2.22% | 4.19% | -45.74% | |
75 Outperform | $54.24B | 9.73 | 12.88% | 2.78% | 5.57% | -16.00% | |
73 Outperform | $59.99B | 13.81 | 17.20% | 2.10% | 7.25% | 37.42% | |
69 Neutral | $38.20B | 10.08 | 36.71% | 1.49% | 66.84% | 83.13% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $36.13B | 14.22 | 10.91% | 4.73% | 4.08% | 54.01% |